	Prognostic Stratification of Initial Treatments for Hepatocellular Carcinoma Using a Modified Borderline Resectable Classification. Cancer Med Tada F, Hiraoka A, Ohama H, Saito M, Kimura Y, Nakamura A, Usui T, Kato K, Onishi K, Kitahata S, Kanemitsu-Okada K, Kawamura T, Kuroda T, Ishimura N, Hanaoka J, Watanabe J, Ohtani H, Miyake T, Yoshida O, Hirooka M, Miyata H, Tsubouchi E, Abe M, Ninomiya T, Hiasa Y. PMID: 41405376 [PubMed - indexed for MEDLINE]
	Facilitating Precision Medicine in HCC Patients by Deep Learning-Directed lncRNAs Classification and Ascertaining Causal Markers. J Gene Med Jain R, Mungamuri SK, Garg P. PMID: 41405166 [PubMed - indexed for MEDLINE]
	LASSO-empowered nomogram integrating nutritional-inflammatory-tumor characteristics predicts immunotherapy outcomes in advanced HCC: Large retrospective cohort. Front Immunol Hu S, Xu M, Li S, Chen W, Peng Z. PMID: 41403946 [PubMed - indexed for MEDLINE]
	Macrophage Polarization in the Tumor Microenvironment of Hepatocellular Carcinoma: From Mechanistic Insights to Translational Therapies. Cancer Control Fu X, Pang M, Wang Z, Wang H. PMID: 41403016 [PubMed - indexed for MEDLINE]
	Analysis of risk factors for early mortality following hepatectomy in hepatocellular carcinoma patients. BMC Surg Kou C, Zhu H, Fan L, Fan W, Cheung TT, Ji R. PMID: 41402783 [PubMed - indexed for MEDLINE]
	Burden and trends of NASH-related liver cancer associated with high fasting plasma glucose in China and globally from 1990 to 2021: a population-based analysis of the global burden of disease study. BMJ Open Yao Y, Ji C, Zhou C, Gui M. PMID: 41401990 [PubMed - indexed for MEDLINE]
	Efficacy and safety of percutaneous microwave ablation for liver tumors using an antenna with anti-phase technology offering ultraspherical ablation. Radiol Oncol Arik E, Taydas O, Dertli T, Sevinc OF, Kara AB, Topaloglu OF, Ozdemir M, Senturk A, Canturk AO, Hacibekiroglu I, Ozturk MH. PMID: 41401063 [PubMed - indexed for MEDLINE]
	Contrast-enhanced US Evaluation of Residual Hepatocellular Carcinoma Following Lenvatinib Combined with Anti-PD-1 Antibody Downstaging Therapy. Radiology Zhu L, Jiang B, Fei X, Xu Y, Liu Z, Zhang W, Liu B, Lu S, Luo Y. PMID: 41400470 [PubMed - indexed for MEDLINE]
	Real-World Efficacy of Transarterial Embolization and Transarterial Chemoembolization in Unresectable Hepatocellular Carcinoma: a Nationwide Cohort Study in Taiwan. Int J Med Sci Huang YH, Hu PJ, Chiu SH, Chang WC, Lin YF, Chang PY. PMID: 41399374 [PubMed - indexed for MEDLINE]
	Liver Transplantation for Combined Hepatocellular-Cholangiocarcinoma: A Retrospective Registry-Based Study Using the Korean Organ Transplant Registry (KOTRY). Ann Transplant Kim SH, Hwang S, Kim BW, Joo DJ, Lee KW, Choi GS, Ryu JH, Kim DS, Choi D, Cho JY, You YK, Choi D, Kim TS, Park P. PMID: 41399117 [PubMed - indexed for MEDLINE]
	Basic research on quercetin in liver cancer: Progress and perspectives. Medicine (Baltimore) Liu B, Yu Y, Wang R, Wu Y, Sun K. PMID: 41398772 [PubMed - indexed for MEDLINE]
	Prognostic and immunological implications of sialylation-associated gene signatures in hepatocellular carcinoma. Ann Med Wang GQ, Du K, Wang YP. PMID: 41398172 [PubMed - indexed for MEDLINE]
	The "silent assassin" of the liver: angiosarcoma with portal hypertension. Med Ultrason Zhang X, Qu N, Cao X. PMID: 41397175 [PubMed - indexed for MEDLINE]
	Concomitant medication use and clinical outcome in hepatocellular carcinoma treated with immune-based therapy: a multicenter analysis. Front Immunol Yi JZ, Xu J, Zeng JZ, Song YJ, Zhang YN, Huang CM, Li L, Ding K, Zhu ZJ, Yuan DZ, Fan YW, Ning SF, Liu X, Zhang JZ, You YF, Zhou Q, Song HJ, Tan GJ, Wu XT, Guo RP, Chen MS, Lyu N, Zhao M. PMID: 41394828 [PubMed - indexed for MEDLINE]
	Predictive value of peripheral blood CD4(+) T and NK cells on efficacy and long-term survival in advanced HCC patients receiving immunotherapy. Front Immunol Pan Z, Song S, An Y, Guan L, Liu H, Li W. PMID: 41394802 [PubMed - indexed for MEDLINE]
	Adrenal crisis occurring after the application of immune checkpoint inhibitors in a hepatitis B - related hepatocellular carcinoma patient: case report and literature review. Front Immunol Guo Y, Zhu Q, Ren W, Li F. PMID: 41394799 [PubMed - indexed for MEDLINE]
	Real-World Survival Outcomes of Atezolizumab and Bevacizumab in Unresectable Hepatocellular Carcinoma Patients With Hepatitis B Virus Infection: A Hospital-Based Cohort Study. Cancer Control Dung NT, Binh NH, Quang BV, Hien TT, Phuong PC, Thang VH. PMID: 41388811 [PubMed - indexed for MEDLINE]
	Glucagon-Like Peptide-1 Receptor Agonists and Hepatocellular Carcinoma Prevention: A Meta-Analysis and Clinical Decision Framework. Cancer Med Dalbeni A, Vicardi M, Natola LA, Cattazzo F, Auriemma A, Lombardi R, Cinque F, Dalle Carbonare L, Mantovani A, Sacerdoti D. PMID: 41388641 [PubMed - indexed for MEDLINE]
	Getting to Implementation: applying data-driven implementation strategies to improve guideline concordant surveillance for hepatocellular carcinoma. Implement Sci Yakovchenko V, Kang C, Neely B, Lamorte C, McCurdy H, Scott D, Nobbe A, Robins G, Ekanem NR, Merante M, Gibson S, Spoutz P, Chia L, Gonzalez RI, Chinman MJ, Ross D, Chartier M, Beste LA, Bajaj JS, Taddei T, Morgan TR, Rogal SS. PMID: 41388318 [PubMed - indexed for MEDLINE]
	The alternative splicing landscape of hepatocellular carcinoma and its potential for HCC detection. Hepatol Commun Hershberger CE, Daniels NJ, Patterson WM, Rotroff DM. PMID: 41385729 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 74691

Page 1 of 3735



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy